Orogen Therapeutics recognized Research Associate Jane Dubrovsky on the Biochemistry team.
Published
Signal category
People
Quote
“Today, we'd like to recognize Jane Dubrovsky, Research Associate on the Biochemistry team at Orogen Therapeutics.”
— Orogen Therapeutics team
Company
Orogen Therapeutics
Pioneering transformative medicines through our AI-enabled DNA-encoded library platform for unmet medical needs.
- Industry
- Biotechnology Research
- Location
- Woburn, US
- Company size
- 19 employees
Orogen Therapeutics is a biotechnology company advancing next-generation small molecule discovery through an AI-enabled DNA-encoded library (DEL) platform. By integrating computational intelligence with precision chemical diversity, we focus on identifying high-quality binders against challenging and high-value biological targets. Our platform is designed to concentrate chemical diversity around biologically relevant binding space, improving hit quality and accelerating the transition from discovery to development. This targeted approach enhances efficiency, reduces attrition risk, and supports the creation of differentiated therapeutic candidates. At Orogen, we are driven by a clear mission: to deliver transformative medicines for patients facing critical unmet medical needs.